Penn Medicine Biobank Return of Results Program

Clinical trial NCT06089954 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06089954
Sponsor: Abramson Cancer Center at Penn Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Genetic Disease Cancer Cardiovascular Diseases

Start date: 2023-10-20
Primary completion: 2026-07-01
Enrollment: 2500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.